These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 311899)

  • 1. Suppressor cells prevent host resistance to tumor growth.
    Schechter B; Feldman M
    Naturwissenschaften; 1979 Mar; 66(3):140-6. PubMed ID: 311899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of suppressor cell activity by hydrocortisone: suppression of in vitro activation of splenocytes from mice bearing Lewis lung carcinoma.
    Clerici E; Schechter B; Feldman M
    Int J Cancer; 1980 Mar; 25(3):349-54. PubMed ID: 6446525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing lymphocytes in spleens of tumor-bearing mice: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    Int J Cancer; 1977 Aug; 20(2):239-46. PubMed ID: 892934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1976 Aug; 57(2):409-14. PubMed ID: 1087347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.
    Umiel T; Trainin N
    Transplantation; 1974 Sep; 18(3):244-50. PubMed ID: 4608685
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells.
    Schechter B; Feldman M
    J Immunol; 1977 Nov; 119(5):1563-8. PubMed ID: 915269
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in cell surface antigens of tumor metastases and those of the local tumor.
    Fogel M; Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
    Gorelik E; Fogel M; Segal S; Feldman M
    J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells.
    Gorelik E; Kedar E; Sredni B; Herberman R
    Int J Cancer; 1981 Aug; 28(2):157-64. PubMed ID: 6976330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of natural killer activity and antibody-dependent cellular cytotoxicity in spleen cells of tumor bearing mice.
    Ono M; Tanaka N; Orita K
    Acta Med Okayama; 1983 Aug; 37(4):367-76. PubMed ID: 6605026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors.
    Acero R; Polentarutti N; Bottazzi B; Alberti S; Ricci MR; Bizzi A; Mantovani A
    Int J Cancer; 1984 Jan; 33(1):95-105. PubMed ID: 6607223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.